Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine

Infection and Immunity

Volumn 74, Issue 3, 2006, Pages 1977-1983

  Gamage, Shantini D ^a   Patton, Angela K ^a   Strasser, Jane E ^b   Chalk, Claudia L ^b   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIOPHAGE; COMMENSAL ESCHERICHIA COLI; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TOXIN SYNTHESIS;

ANIMALS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; INTESTINES; MICE; SHIGA TOXIN; SYMBIOSIS;

EID: 33644767373     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.3.1977-1983.2006     Document Type: Article

References (27)

1. Asahara, T., K. Shimizu, K. Nomoto, T. Hamabata, A. Ozawa, and Y. Takeda. 2004. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72:2240-2247.
2. Bengmark, S. 1998. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 42:2-7.
3. Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.
4. Bullock, J. O., S. K. Armstrong, J. L. Shear, D. P. Lies, and M. A. McIntosh. 1990. Formation of ion channels by colicin B in planar lipid bilayers. J. Membr. Biol. 114:79-95.
5. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
6. Gamage, S. D., C. M. McGannon, and A. A. Weiss. 2004. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2. J. Bacteriol. 186:5506-5512.
7. Gamage, S. D., A. K., Patton, J. F. Hanson, and A. A. Weiss. 2004. Diversity and host range of Shiga toxin-encoding phage. Infect. Immun. 72:7131-7139.
8. Gamage, S. D., J. E. Strasser, C. L. Chalk, and A. A. Weiss. 2003. Non-pathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect. Immun. 71:3107-3115.
9. Huang, A., S. de Grandis, J. Friesen, M. Karmali, M. Petric, R. Congi, and J. L. Brunton. 1986. Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19. J. Bacteriol. 166:375-379.
10. Kimmitt, P. T., C. R. Harwood, and M. R. Barer. 1999. Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones. Lancet 353:1588-1589.
11. Kimmitt, P. T., C. R. Harwood, and M. R. Barer. 2000. Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg. Infect. Dis. 6:458-465.
12. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
13. Miranda, R. L., T. Conway, M. P. Leatham, D. E. Chang, W. E. Norris, J. H. Allen, S. J. Stevenson, D. C. Laux, and P. S. Cohen. 2004. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect. Immun. 72:1666-1676.
14. Plunkett, G., III, D. J. Rose, T. J. Durfee, and F. R. Blattner. 1999. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J. Bacteriol. 181:1767-1778.
15. Selander, R. K., D. A. Caugant, and T. S. Whittam. 1987. Genetic structure and variation in natural populations of Escherichia coli, p. 1625-1648. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology, vol. 2. American Society for Microbiology, Washington, D.C.
16. Shu, Q., and H. S. Gill. 2002. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 34:59-64.
17. Slutsker, L., A. A. Ries, K. D. Greene, J. G. Wells, L. Hutwagner, and P. M. Griffin. 1997. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann. Intern. Med. 126:505-513.
18. Smith, H. W., P. Green, and Z. Parsell. 1983. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J. Gen. Microbiol. 129:3121-3137.
19. Sperandio, V., J. L. Mellies, W. Nguyen, S. Shin, and J. B. Kaper. 1999. Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 96:15196-15201.
20. Sperandio, V., A. G. Torres, B. Jarvis, J. P. Nataro, and J. B. Kaper. 2003. Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. USA 100:8951-8956.
21. Surette, M. G., and B. L. Bassler. 1998. Quorum sensing in Escherichia coli and Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 95:7046-7050.
22. Surette, M. G., M. B. Miller, and B. L. Bassler. 1999. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc. Natl. Acad. Sci. USA 96:1639-1644.
23. Takahashi, M., H. Taguchi, H. Yamaguchi, T. Osaki, A. Komatsu, and S. Kamiva. 2004. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 41:219-226.
24. Wadolkowski, E. A., J. A. Burris, and A. D. O'Brien. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58:2438-2445.
25. Wagner, P. L., M. N. Neely, X. Zhang, D. W. Acheson, M. K. Waldor, and D. I. Friedman. 2001. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J. Bacteriol. 183:2081-2085.
26. Wong, C. S., S. Jelacic, R. L. Habeeb, S. L. Watkins, and P. I. Tarr. 2000. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342:1930-1936.
27. Zhang, X., A. D. McDaniel, L. E. Wolf, G. T. Keusch, M. K. Waldor, and D. W. Acheson. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181:664-670.